These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18205394)

  • 21. Identification of a novel mutation in a Korean patient with oculopharyngeal muscular dystrophy.
    Bae JS; Ki CS; Kim JW; Kim BJ
    J Clin Neurosci; 2007 Jan; 14(1):89-92. PubMed ID: 17138075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly-(L-alanine) expansions form core beta-sheets that nucleate amyloid assembly.
    Shinchuk LM; Sharma D; Blondelle SE; Reixach N; Inouye H; Kirschner DA
    Proteins; 2005 Nov; 61(3):579-89. PubMed ID: 16114037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation.
    Périé S; Mamchaoui K; Mouly V; Blot S; Bouazza B; Thornell LE; St Guily JL; Butler-Browne G
    Neuromuscul Disord; 2006 Nov; 16(11):770-81. PubMed ID: 17005403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dynamism of PABPN1 nuclear inclusions during the cell cycle.
    Marie-Josée Sasseville A; Caron AW; Bourget L; Klein AF; Dicaire MJ; Rouleau GA; Massie B; Langelier Y; Brais B
    Neurobiol Dis; 2006 Sep; 23(3):621-9. PubMed ID: 16860991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal model of oculopharyngeal muscular dystrophy.
    Uyama E; Hino H; Araki K; Takeya M; Uchino M; Yamamura K
    Acta Myol; 2005 Oct; 24(2):84-8. PubMed ID: 16550922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation.
    Davies JE; Sarkar S; Rubinsztein DC
    Hum Mol Genet; 2008 Apr; 17(8):1097-108. PubMed ID: 18178579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle.
    Banerjee A; Phillips BL; Deng Q; Seyfried NT; Pavlath GK; Vest KE; Corbett AH
    J Biol Chem; 2019 May; 294(18):7360-7376. PubMed ID: 30837270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein.
    Raz V; Routledge S; Venema A; Buijze H; van der Wal E; Anvar S; Straasheijm KR; Klooster R; Antoniou M; van der Maarel SM
    Am J Pathol; 2011 Oct; 179(4):1988-2000. PubMed ID: 21854744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects.
    Rivera D; Mejia-Lopez H; Pompa-Mera EN; Villanueva-Mendoza C; Nava-Castañeda A; Garnica-Hayashi L; Cuevas-Covarrubias S; Zenteno JC
    Br J Ophthalmol; 2008 Jul; 92(7):998-1002. PubMed ID: 18577654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation.
    Robinson DO; Wills AJ; Hammans SR; Read SP; Sillibourne J
    J Med Genet; 2006 May; 43(5):e23. PubMed ID: 16648376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preferential distal muscle involvement in case of oculopharyngeal muscular dystrophy with (GCG) 13 expansion].
    Nakashima D; Nakajima H; Ishida S; Sugino M; Kimura F; Hanafusa T
    Rinsho Shinkeigaku; 2003 Sep; 43(9):560-3. PubMed ID: 14727564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.
    Barbezier N; Chartier A; Bidet Y; Buttstedt A; Voisset C; Galons H; Blondel M; Schwarz E; Simonelig M
    EMBO Mol Med; 2011 Jan; 3(1):35-49. PubMed ID: 21204267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
    Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
    Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of expression and co-localization of heat shock polypeptides with the polyalanine expansion mutant of poly(A)-binding protein N1 after chemical stress.
    Wang Q; Bag J
    Biochem Biophys Res Commun; 2008 May; 370(1):11-5. PubMed ID: 18343218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (GCG)11 founder mutation in the PABPN1 gene of OPMD Uruguayan families.
    Rodríguez M; Camejo C; Bertoni B; Braida C; Rodríguez MM; Brais B; Medici M; Roche L
    Neuromuscul Disord; 2005 Feb; 15(2):185-90. PubMed ID: 15694141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy.
    Bengoechea R; Tapia O; Casafont I; Berciano J; Lafarga M; Berciano MT
    Neurobiol Dis; 2012 Apr; 46(1):118-29. PubMed ID: 22249111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational stability of the RNP domain controls fibril formation of PABPN1.
    Liebold J; Winter R; Golbik R; Hause G; Parthier C; Schwarz E
    Protein Sci; 2015 Nov; 24(11):1789-99. PubMed ID: 26267866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus.
    Berciano MT; Villagra NT; Ojeda JL; Navascues J; Gomes A; Lafarga M; Carmo-Fonseca M
    Hum Mol Genet; 2004 Apr; 13(8):829-38. PubMed ID: 14976164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A folded and functional protein domain in an amyloid-like fibril.
    Sackewitz M; von Einem S; Hause G; Wunderlich M; Schmid FX; Schwarz E
    Protein Sci; 2008 Jun; 17(6):1044-54. PubMed ID: 18424511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability of the recessive oculopharyngeal muscular dystrophy phenotype.
    Semmler A; Kress W; Vielhaber S; Schröder R; Kornblum C
    Muscle Nerve; 2007 May; 35(5):681-4. PubMed ID: 17206657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.